Grover May, MD
Obstetrics & Gynecology · Johnson City, TNNPI 1497750657
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $566,247 of the $916,311 with a category attached, or 61.8%. Applied Medical Resources Corporation accounts for 99.6% of it on its own, with 30 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 735 payments — averaging $1246.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Medical Resources Corporation$913K
- Coopersurgical, Inc.$352
- Baxter Healthcare$328
- Intuitive Surgical$310
- AbbVie$276
- Teleflex LLC$254
- plus $2K from 25 others
What the payments were for
- Consulting fees$241,46926%
- Speaking & faculty fees$566,24762%
- Travel & lodging$83,8349%
- Food & beverage$23,9753%
- Education$7860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Medical Resources Corporation | 614 | $912,996 |
| Coopersurgical, Inc. | 8 | $352 |
| Baxter Healthcare | 5 | $328 |
| Intuitive Surgical | 4 | $310 |
| AbbVie(2 entities) | 14 | $276 |
| Teleflex LLC | 5 | $254 |
| Astellas Pharma US Inc | 11 | $187 |
| Momentis Surgical Inc. | 1 | $179 |
| Mayne Pharma Commercial LLC | 11 | $168 |
| Conmed Corporation | 2 | $156 |
| Sumitomo Pharma America, Inc. | 6 | $135 |
| Asensus Surgical, Inc. | 3 | $100 |
| Boston Scientific | 5 | $97 |
| Daiichi Sankyo Inc. | 6 | $97 |
| Myovant Sciences Inc. | 5 | $78 |
| Exeltis, USA Inc. | 5 | $76 |
| Bayer | 5 | $74 |
| Aspira Women's Health Inc | 1 | $59 |
| Dilon Technologies, Inc. | 1 | $55 |
| Avion Pharmaceuticals | 4 | $53 |
| Urovant Sciences Inc | 2 | $47 |
| Organon | 3 | $46 |
| Therapeuticsmd, Inc. | 3 | $42 |
| Pfizer | 2 | $29 |
| Lupin Inc. | 2 | $23 |
| AMAG Pharmaceuticals, Inc. | 2 | $23 |
| Novo Nordisk | 1 | $16 |
| Caldera Medical, Inc | 1 | $16 |
| Amgen | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $12 |
| Olympus America Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GelPOINT V-Path$858,879
- GELPOINT$47,704
- ALEXIS CONTAINED EXTRACTION SYSTEM$47,704
- GELPORT$39,668
- GELPOINT VPATH$30,511
- VOYANT$5,623
- GelPOINT Path Transanal Access Platform$3,000
- Gelport Laparoscopic System$1,336
- Soft/Traction Clamp Inserts$1,248
- GELPOINT MINI$500
- ALEXIS WOUND PROTECTOR/RETRACTOR$300
- Hominis Surgical System$179
- Da Vinci Surgical System$115
- Uterine Manipulators & Injectors$114
- Orilissa$104
- Obstetrical Products$101
How this compares
$916,311 in reported general payments places this provider in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 17 | $9,410 |
| Estradiol | 28 | $645 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $62 |
| Ibuprofen | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $187 | $9,41017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Other obstetrics & gynecology in Johnson City
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
- Larry FieldsKnoxville$323K
- Michael SwanNashville$146K
- Clarinda Burton-ShannonLebanon$114K
- Royce AdkinsNashville$95K
- Olga MuldoonNashville$91K
- Kimberly LooneyNashville$84K
- Bert GeerCookeville$83K
- Benjamin ChappellMemphis$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.